Cryptococcal Meningitis: Clinical Trials

3 trials for Cryptococcal Meningitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow Cryptococcal Meningitis: new trials by email Literature Review of Cryptococcal Meningitis trials Research Report on Cryptococcal Meningitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
MAT2203, Amphotericin B - Cryptococcal Meningitis
Phase 1 / Phase 2CompletedMatinas BioPharma Nanotechnologies, Inc.1782019-10-242023-03-31
Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report
Vietnam Cryptococcal Retention in Care Study (CRICS) - Cryptococcal Meningitis
Phase 1CompletedNational Hospital for Tropical Diseases, Hanoi, Vietnam11772015-06-012018-03-29
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Fluconazole, Amphotericin B - Cryptococcal Meningitis, HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1682010-04-162021-11-04

Narrower conditions

Meningitis, Cryptococcal (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  HIV Infections (1)  ·  Meningitis (1)

Broader conditions

Bacterial Infections and Mycoses (3)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Fungal Infections (3)  ·  Central Nervous System Infections (3)  ·  Cryptococcosis (3)  ·  Infections (3)  ·  Meningitis, Fungal (3)  ·  Mycoses (3)  ·  Nervous System Diseases (3)  ·  Neuroinflammatory Diseases (3)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)

Interventions

Amphotericin B (2)  ·  Fluconazole (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  liposomal amphotericin B (1)

Sponsors

Matinas BioPharma Nanotechnologies, Inc. (1)  ·  National Hospital for Tropical Diseases, Hanoi, Vietnam (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Uganda (2)  ·  India (1)  ·  Kenya (1)  ·  Peru (1)  ·  South Africa (1)  ·  Thailand (1)  ·  United States (1)  ·  Vietnam (1)  ·  Zimbabwe (1)

Top investigators

Nguyen V Kinh, Dr (1)  ·  Robert A. Larsen, MD (1)  ·  Umesh G. Lalloo, MD, FRCP (1)

Results publications

PMID 32747357, PMID 34446679, PMID 36780493, PMID 37606364, PMID 38943665, PMID 39972326, PMID 40665233